DSM Buys Device Component Maker Kensey Nash To Bolster Biomedical Materials Offerings
This article was originally published in The Gray Sheet
Executive Summary
Deal worth $360 million will help establish DSM as a major device industry materials supplier, strengthening offerings of bio-passive, bio-active and bio-interactive materials technologies.